Business Context and Reporting Period
This Form 8-K was filed by WellPoint, Inc. (now Elevance Health, Inc.) on July 31, 2013, reporting events that occurred on July 30, 2013. The filing details a significant capital market transaction involving the issuance of new debt securities and the initiation of tender offers for existing debt.
Key Financial Metrics and Transaction Details
- New Debt Issuance: The Company issued $650 million of 2.300% Notes due 2018 and $600 million of 5.100% Notes due 2044, totaling $1.25 billion in aggregate principal amount.
- Net Proceeds: The Company anticipates receiving approximately $1.234 billion in net proceeds after deducting underwriting discounts and offering expenses.
- Use of Proceeds: Funds are primarily intended to finance the purchase of "Tender Notes" (existing debt) and pay associated accrued interest and premiums. Remaining proceeds will be used for general corporate purposes, including repurchasing other outstanding indebtedness.
- Tender Offers: The Company commenced tender offers to purchase up to $600 million aggregate principal amount of its outstanding notes.
- Interest Payments: Interest on the new Notes is payable semi-annually on January 15 and July 15, commencing January 15, 2014.
Material Changes and Debt Structure
The filing represents a material change in the Company's capital structure through the refinancing of existing obligations. The new Notes are issued under an existing Indenture dated January 10, 2006. The Indenture does not prohibit or limit the incurrence of additional indebtedness. The transaction involves a mix of short-term (2018) and long-term (2044) debt instruments to manage the Company's maturity profile.
Terms, Risks, and Contingencies
- Redemption Rights: The Company may redeem the Notes at its option. The redemption price is the greater of 100% of the principal amount or the present value of remaining payments discounted at the Treasury Rate plus a spread (15 basis points for 2018 Notes; 25 basis points for 2044 Notes).
- Change of Control: If a change of control occurs and the Notes are downgraded below investment grade by Moody's, S&P, and Fitch, the Company must offer to repurchase the Notes at 101% of the principal amount plus accrued interest.
- Events of Default: Default triggers include failure to pay principal or interest, breach of indenture terms for 60 days, or bankruptcy proceedings. Upon default, the Trustee or holders of 25% of the Notes may declare the debt immediately due and payable.
- Underwriter Relationships: Morgan Stanley & Co. LLC and Citigroup Global Markets Inc. acted as representatives. Affiliates of the underwriters provide other banking services and participate in the Company's revolving credit agreement.
Investor Verification Checklist
- Verify the final amount of Tender Notes accepted and the total cash outflow required to settle the tender offers.
- Confirm the final net proceeds received after all transaction costs are settled.
- Review the "Computation of Ratio of Earnings to Fixed Charges" (Exhibit 12.1) to assess the impact of the new debt service on leverage ratios.
- Monitor credit rating actions by Moody's, S&P, and Fitch to determine if the change of control provision is triggered.
- Check subsequent filings for the actual date of closing and the final allocation of proceeds between debt retirement and general corporate purposes.